Prostaglandin E1 attenuates post-cardiac arrest myocardial dysfunction through inhibition of mitochondria-mediated cardiomyocyte apoptosis

Post-cardiac arrest myocardial dysfunction (PAMD) is a leading cause of death in patients undergoing resuscitation patients following cardiac arrest (CA). Although prostaglandin E1 (PGE1) is a clinical drug used to mitigate ischemia injury, its effect on PAMD remains unknown. In the present study, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Chenglei, Fan, Xinhui, Xu, Feng, Wang, Jiali, Chen, Yuguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723157/
https://www.ncbi.nlm.nih.gov/pubmed/33300050
http://dx.doi.org/10.3892/mmr.2020.11749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723157/
https://www.ncbi.nlm.nih.gov/pubmed/33300050
http://dx.doi.org/10.3892/mmr.2020.11749

Ejemplares similares